Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2022-12-09 00:00:00 ET · period of report 2022-12-07 · accession 0001415889-22-012355 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-09 | 2022-12-07+ | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $21.85 | -23.6K | 1,960 | -92% | -$516.8K |
| DM | 2022-12-09 | 2022-12-07+ | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +23.6K | 13.6K | New | +$50.6K |
| DM | 2022-12-09 | 2022-12-07+ | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $0.00 | -23.6K | 40.7K | -37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-08 | S | D | 20 | $20.58 | 12,991 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-08 | S | D | 960 | $20.12 | 13,011 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.575 to $20.54, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2022-12-08 | M | A | 12,011 | $2.14 | 13,971 | D | — | — | |
| 4 | Common | Common Stock | 2022-12-07 | S | D | 4,558 | $20.40 | 1,960 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.02 to $20.56, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2022-12-07 | S | D | 7,079 | $19.37 | 6,518 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.97, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 6 | Common | Common Stock | 2022-12-07 | M | A | 11,637 | $2.14 | 13,597 | D | — | — | |
| 7 | Common | Common Stock | 2022-12-08 | S | D | 11,031 | $24.20 | 1,960 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.50, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-12-08 | M | D | 1,887 | $0.00 | 82,769 | D | $2.14 · — to 2031-04-01 | 1,887 Common Stock | (F6) A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 9 | Derivative | Stock Option (Right to Buy) | 2022-12-07 | M | D | 11,637 | $0.00 | 84,656 | D | $2.14 · — to 2031-04-01 | 11,637 Common Stock | (F6) A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 10 | Derivative | Stock Option (Right to Buy) | 2022-12-08 | M | D | 10,124 | $0.00 | 40,726 | D | $2.14 · — to 2031-04-01 | 10,124 Common Stock | (F7) A total of 50,850 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on March 22, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |